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Background: The sole focus of models of insight on bio-medical perspectives to the complete exclusion of local,
non-medical and cultural constructs mandates review. This study attempted to investigate the impact of insight,
psychopathology, explanatory models of illness on outcome of first episode schizophrenia.
Method: Patients diagnosed to have DSM IV schizophrenia (n = 131) were assessed prospectively for insight,
psychopathology, explanatory models of illness at baseline, 6, 12 and 60 months using standard instruments.
Multiple linear and logistic regression and generalized estimating equations (GEE) were employed to assess
predictors of outcome.
Results: We could follow up 95 (72.5%) patients. Sixty-five of these patients (68.4%) achieved remission. There was
a negative relationship between psychosis rating and insight scores. Urban residence, fluctuating course of the
initial illness, and improvement in global functioning at 6 months and lower psychosis rating at 12 months were
significantly related to remission at 5 years. Insight scores, number of non-medical explanatory models and
individual explanatory models held during the later course of the illness were significantly associated with outcome.
Analysis of longitudinal data using GEE showed that women, rural residence, insight scores and number of
non-medical explanatory models of illness held were significantly associated with BPRS scores during the study
period.
Conclusions: Insight, the disease model and the number of non-medical model positively correlated with
improvement in psychosis arguing for a complex interaction between the culture, context and illness variables.
These finding argue that insight and explanatory models are secondary to psychopathology, course and outcome
of the illness. The awareness of mental illness is a narrative act in which people make personal sense of the many
challenges they face. The course and outcome of the illness, cultural context, acceptable cultural explanations and
the prevalent social stigma interact to produce a complex and multifaceted understanding of the issues. This
complexity calls for a nuanced framing of insight.
Keywords: Schizophrenia, Outcome, Insight, Explanatory models, CultureBackground
The term insight, employed in the context of self-
awareness, has been used in many different ways. It
ranges from a basic awareness of one’s situation to a
deeper intellectual understanding and emotional appre-
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reproduction in any medium, provided the ordifferent disciplines (e.g. psychoanalysis) to imply par-
ticular understanding. Assessment in clinical psychiatry
terms insight as “a patient’s capacity to understand the
nature, significance and severity of his or her illness” [1].
Such awareness has major clinical implications for phe-
nomenology, clinical management, coping, help seeking
and treatment compliance.
Research related to insight and schizophrenia has
changed substantially over the past few decades. Olderl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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employed uni-dimensional and all-or-none perspectives
in the elicitation of insight [2,3]. They concluded that
the majority of people with schizophrenia “lacked
insight”. This was consistently demonstrated in acute
and chronic schizophrenia and across national and cul-
tural settings. Recent investigations have employed a
more sophisticated approach to insight and employed
multi-dimensional perspectives [4-9]. These models
include the awareness of one’s suffering, the appreciation
of certain beliefs, perceptions and experiences and their
medical implications [4,5]. The concepts and instru-
ments focus on relabeling of the experience, recognition
of mental illness and seeking medical and psychiatric
help. These assessment have been used to study the cor-
relation between insight, psychopathology, explanatory
models, disability, social issues and biology [6,8-13].
Nevertheless, the more recent approaches have also
been criticised [14-17]. Their sole focus on the biomed-
ical/disease model, the cost of labeling and stigma have
been highlighted as limitation. Investigators have high-
lighted the arrogance of bio-medical views as local cul-
ture and non-western beliefs are excluded even when
such investigations are done in the non-western world.
Many investigations, from non-western cultures, have
recorded the simultaneous presence of multiple and
contradictory models of illness in people [8,18-23]. Non-
medical beliefs (e.g. karma, evil spirits, black magic, sin,
punishment by God, etc.) compete with biomedical con-
cepts of illness (e.g. disease, degeneration, deficiency, etc.).
Patients select the health care system from the diverse
range of facilities available for cure and healing. The
co-existence of traditional and modern systems of medi-
cine means that these facilities compete for providing
health care to people with different illnesses. This is con-
sidered the norm in low and middle income countries but
has also been recorded in western populations [20,24].
Pluralistic societies employ multiple approaches to
health and illness. Disease models of causation are
almost universal in rural India and in low and middle-
income countries for illnesses of short duration
(e.g. fever, diarrhea [25,26]). In fact, physicians are under
pressure to provide immediate relief from symptoms. On
the other hand, people employ multiple explanatory mod-
els of illness to explain chronic diseases, especially those
with variable response to medical treatment, course and
outcome [27]. The simultaneous use of contradictory
models suggests their use in coping with different aspects
of the condition.
This study attempted to study the impact of local cul-
tural explanations, attributions and actions on the long-
term outcome of first episode schizophrenia in Vellore,
India. It employs a cohort design where the patients were
followed-up for 5 years after the initial recruitment.Method
Study site
This study was carried out in the Department of Psych-
iatry, Christian Medical College, Vellore, Tamil Nadu,
south India. The total area of Vellore district is
4314.29 km2. The 122-bed hospital provides short-term
care psychiatric care for the town, the district and a
much wider rural area beyond. The department treats a
variety of mental and behavioural disorders with a
multi-disciplinary and eclectic approach using standard
pharmacological and psychological therapies. The hos-
pital has a daily outpatient clinic in which about 350–
400 patients are seen. Patients requiring hospitalization
are admitted for a period of 2–6 weeks.
The hospital follows standard protocols for the treat-
ment of patients with schizophrenia. Antipsychotic
medication (e.g. risperidone, olanzapine, chlorpromaz-
ine) are drugs of choice and employed in adequate doses
(e.g. 4–8 mg of risperidone, 15–25 mg of olanzapine and
400–1000 mg of chlorpromazine) and for a period of
about 2 years for people with first episode of psychosis.
Clozapine is reserved for patients who do not respond
to at least 2 antipsychotic drugs given in adequate dose
for at least 6–12 weeks. All patients admitted to the hos-
pital also receive psychoeducation, supportive psycho-
therapy and occupational therapy. Patients with specific
problems related to marriage, sex, interpersonal and
vocational issues are helped by psychological interven-
tions (e.g. cognitive and behavioural therapy).
Sample and procedures
The details of the cohort are described in other publica-
tions [8,18,19]. The study group consisted of patients
with schizophrenia having their first contact with mental
health services and living within a 100 km radius of the
study site. Patients were carefully screened for a DSM
IV diagnosis of schizophrenia [28]. The details of the
study were explained and written informed consent was
obtained. The following instruments were employed for
assessment at baseline:
(i) Structured Clinical Interview for DSM-III R Patient
version (SCID-P): We used the Structured Clinical
Interview for DSM-III R Patient version (SCID-P) to
assess psychopathology and confirm diagnosis [29].
It is a structured and comprehensive interview to
assess psychopathology and confirm diagnosis.
Patients with a primary diagnosis of substance use
disorders, mood disorder or organic mental
disorders were excluded. This instrument has been
employed in many local studies [30,31].
(ii) Schedule for Assessment of Insight Expanded (SAI-E):
[32,33]. The schedule comprises of questions to
assess three dimensions of insight: awareness,
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‘hypothetical contradiction’ item added to evaluate the
person’s capacity to consider another’s perspective.
Each dimension comprises of two or three questions,
which are scored on a 3-point scale. The
supplementary question is scored from 0 to 4 and this
is added to the total score. The instrument also
includes items on awareness of change, difficulties
resulting from the mental condition and insight into
key symptoms. The instrument has been widely
employed in western and non-western cultures [34,35].
(iii)Brief Psychiatric Rating Scale (BPRS): [36] The scale
is commonly employed to assess patients with
psychosis. It has a recommended interview schedule,
symptom definitions, and specific anchor points for
rating symptoms and behaviors. It has self-report
items and those rated based on observed behavior
and speech. Each item is rated between 1 and 7.
(iv)Short Explanatory Model Interview (SEMI): [20,21].
The interview explores emic perspectives of illness. It
employs open-ended questions and is semi-structured.
The subjects are encouraged to talk openly about their
attitudes and experience with the aim of eliciting
concepts held, and relationship to current situation
and culture. Probes are also employed to confirm the
concepts mentioned and to explore areas, which the
patients did not volunteer. The interview is divided
into five sections to cover the subject’s background,
nature of presenting problem, help seeking behaviour,
interaction with physician/healer, and beliefs related to
mental illness. The individuals beliefs related to the
nature of the presenting problem are examined in
detail and include the reason for consulting, name of
the problem, perceived causes, consequences, severity
and its effects on body, emotion, social network, home
life and on work. Emic symptoms are elicited by open-
ended probing. Help seeking behaviour, especially
contact with alternative non-medical sources (e.g.
traditional healers) are also examined. The answers to
the questions were recorded verbatim. Items were
enumerated and the broad facets identified. Item,
which occurred frequently, were allocated
independent codes. Subsequently, SEMI data was
analysed and emic items coded dichotomously (not
reported/reported). The SEMI has been translated into
many different languages and used among people of
different cultures. It has also been used to elicit
perspectives among Indian populations. [37-39]. The
Tamil version [39-41] was used in this study.
(v)Global Assessment of Functioning (GAF) [42]: This
scale was employed to assess overall function.
We used Tamil versions of the instruments. The cohort
was followed up at 6 and 12 months as part of the initialstudy [8,18,19]. The patients continued to receive treat-
ment at the psychiatric hospital. We then attempted to
follow up all the 131 patients at 60 months. We assessed
patients who regularly attended the hospital. We visited
and interviewed all other patients in their homes.
Outcome assessments
We used the following instruments to assess outcomes
at 5 years: (i) Schedule for Assessment of Insight
Expanded (SAI-E), [32,33] (ii) the Brief Psychiatric
Rating Scale (BPRS), [36] (iii) Short Explanatory Model
Interview (SEMI), [20,21]. We also employed the follow-
ing instrument to assess outcome:
(i) Positive and Negative Syndrome Scale (PANSS), [43].
The 30-item scale is commonly used to assess people
with schizophrenia and psychosis. It is comprehensive
and has 7 items for positive symptoms, 7 items for
negative symptoms and 16 items to assess general
psychopathology. Each item has a 7-point severity
scale. Its concurrent and predictive validity and
sensitivity to change have been established.
(ii) WHO Disability Assessment Schedule (WHODASS
II) [44]. The instruments provides a profile of
functioning across six activity domains as well as a
global disability score. It can be used to identify
needs, match patients with interventions, track
functioning across time, and measure clinical
outcome and treatment effectiveness. The Tamil
version has been used locally [45].(iii) A pro forma to clinical details and data on
medication compliance.
We defined remission as being less than mild on all
items P1, P2, P3, N1, N4, N6, G5, G9 on PANSS [46]
using standard criteria.
Statistical analysis
We used descriptive statistics to describe continuous
variables and frequency distributions for categorical vari-
ables. We calculated odds ratios and their 95% confi-
dence intervals. We employed multiple linear and
logistic regression for multivariable analysis. We
employed Generalized Estimating Equations (GEE) ana-
lysis to analyse longitudinal, repeated and correlated
data. We used the SPSS version 16 for analysis.
The Institutional Review Board of the Christian Medical
College, Vellore, approved the study protocols.
Results
Over the 1-year recruitment period, 196 patients with
schizophrenia attended the Department of Psychiatry,
Christian Medical College, Vellore, and 188 met the
entry criteria. Of these 37 were excluded because the
Table 1 Details of course and outcome of the sample at
5 years
Characteristic No. (%) Median Mean (SD) Range
Remission 65 (68.4) - - -
No. with relapses of
psychosis after initial episode
24 (25.2) - - -
No. who returned to
pre-morbid functioning1
14 (14.7) - - -
Regular hospital attendance
over 5 years2
22 (23.2) - - -
Regular medication
compliance over 5 years3




PANSS Total score - 34 43.99 (17.42) 30-92
BPRS Total score - 27 33.87 (15.85) 24-92
SAI-E Total score - 33 26.02 (12.18) 1-35
WHODAS II Total score - 8 12.72 (13.52) 0-48
Total duration of illness
since onset (months)
- 80 91.3 (32.0) 24-252
Total duration in psychotic
episodes since onset
(months)
- 48 56.1(40.6) 8-192
No. of visits to hospital
in 5 years6
- 19 22.3 (13.9) 2-54
No. of missed appointments
over 5 years6




- disease model 52 (54.7)
- non-medical model 43 (45.3)
BPRS- Brief Psychiatric Rating Scale; SAI-E- Schedule for Assessment of Insight-
Expanded; PANSS- Positive and Negative Syndrome Scale; WHODAS-II-WHO
Disability Assessment Scale-II; 1-Pre-morbid functioning assessment by
consensus between medical record and primary carer’s evaluation; 2- Regular
hospital attendance over 5 years as per medical records; 3- Medication
compliance assessment by consensus between medical record and primary
carer’s evaluation; 4- Supervision of medication by family/carer over 5-year
period; 6- as per medical records.
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did not attend and 6 refused consent, yielding a final
sample of 131 participants [8,18,19]. The majority of the
sample were young adults (mean age 29.5 years; sd 7.2),
male (n = 72; 55%), lived in rural areas (n = 105; 80.2%)
and were literate (n = 100; 76.3%). The average age of
onset of illness was 27.8 years (sd 6.85) with a mean dur-
ation of 95.5 weeks (sd 134.2). 16 (12.2%) were voluntary
patients while the rest (n = 115; 87.8%) had involuntary
status. The mean BPRS and SAI-E scores were 56.7 (sd 5.2)
and 4.7 (sd 4.57) respectively. Many patients held specific
causal models of illness including black magic
(n = 96; 73.3%), evil spirits (n = 23; 17.6%), punish-
ment by God (n = 14; 10.7%), previous deeds (n = 12;
9.2%) hereditary factors (n = 1; 0.8%), disease (n = 17;
13.7%) and psychosocial factors (n = 14; 10.7%). 29
(22%) of patients held multiple causal models while
47 (35.9%) held multiple treatment models.
Of the 131 patients in the cohort, 95 (72.5%) were fol-
lowed up at 5 years and interviewed. Five patients had
died (suicide = 2; natural death = 3) and the remaining 31
were not traceable as they had moved out of the area.
There were no statistically significant differences be-
tween the subjects lost to follow up and those who parti-
cipated in the study at 5 years on the following baseline
variables: age, sex, residence, literacy, education, employ-
ment, family history of mental illness, age of onset of ill-
ness, number of non-medical explanatory models, BPRS
and SAI-E scores and visits to traditional healers.
5-year outcome
Table 1 records details of course and outcome over the
5-year period. The majority of subjects met remission
criteria while a minority reached their pre-morbid level
of functioning, were regular with medication and with
follow up at the hospital. A little over half the subjects
admitted that they believed that the disease model was
their best explanation for their illness, while the rest pre-
ferred non-medical explanatory models.
Correlations at 5th year assessment
Insight scores at 5-year follow up was negatively correlated
with psychopathology [BPRS total score (Pearson’s Corr.
coeff. -0.57; p = 0.000), PANSS total score (Pearson’s Corr.
coeff. -0.66; p= 0.000)] and disability (Pearson’s Corr. coeff.
-0.53; p= 0.000) and positively with the total number of
non-medical models (Pearson’s Corr. coeff. 0.37; p = 0.000).
BPRS total score (β=−0.55; t =−6.13; p= 0.000), PANSS
total score (β=−0.65; t =−0.77; p= 0.000), disability
(β=−0.51; t =−05.6; p = 0.000) and the number of nonme-
dical explanatory models (β=0.356 t =−0.32; p = 0.001)
remained statistically significantly associated with insight
after adjustment for age, sex, literacy and residence using
multiple linear regression.The total number of non-medical explanatory models
at 5th year follow up was significantly correlated nega-
tively with psychopathology [BPRS score (Pearson’s Corr.
coeff. -0.36; p = 0.000), PANSS total score (Pearson’s
Corr. coeff. -0.42; p = 0.000)] and disability (Pearson’s
Corr. coeff. -0.30; p = 0.003) and positively with insight
scores (Pearson’s Corr. coeff.0.37; p = 0.000). BPRS total
score (β=−0.32; t =−3.33; p = 0.001), PANSS total score
(β=−0.39; t =−4.2; p = 0.000), disability (β=−0.26;
t =−2.7; p = 0.000) and insight score (β= 0.31; t =−3.3;
p = 0.001) remained statistically significantly associated
with the total number of non-medical models after
adjustment for age, sex, literacy and residence using
multiple linear regression.
Johnson et al. BMC Psychiatry 2012, 12:159 Page 5 of 12
http://www.biomedcentral.com/1471-244X/12/159Factors associated with clinical remission
Table 2 documents the factors associated with remission at
5 years on bivariate analysis. Table 3 and Table 4 record
the relationships between remission on one hand and clin-
ical variables and explanatory model variables respectively
on the other, using multivariate procedures. Variables at
baseline, which were statistically significant on bivariate
analysis, and those variables significantly related at 0, 6, 12
and 60 months were employed for the multivariate statis-




Sex- male 38 (58.5)
Residence- urban 17 (26.2)
No. of meals/day – 2 or less 22 (33.8)
Duration of untreated psychosis >48 weeks1 27 (41.5)
Fluctuating nature of initial illness 54 (83.1)
Explanatory model- evil spirit 8 (12.3)
SAI-E score >31 41 (64.1)
6-month data
SAI-E score >71 33 (60.0)
GAF score > 561 33 (60.0)
12-month data
SAI-E score >141 37 (61.7)
BPRS score > 291 26(43.3)
GAF score > 641 36 (60.0)
Belief in disease model as causal for illness- present 30 (46.2)
60-month data
SAI-E score >331 48 (73.8)
BPRS score > 271 1(1.5)
WHODAS II score >81 21 (32.3)
Belief in disease model as causal for illness- present 49 (75.4)
Belief in evil spirits as causal for illness- present 1 (1.5)
Belief in black magic as causal for illness- present 6 (9.2)
At least one non-medical explanatory model 59 (90.8)
Belief in disease model plus at least one non-medical model 48 (73.8)
Preferred causal explanatory model - disease model 50 (76.9)
Preferred causal explanatory model – non-medical model 15(23.1)
Median used to dichotomize continuous variables; BPRS- Brief Psychiatric Rating Sca
Negative Syndrome Scale; OR- Odds Ratio; 95%CI- 95% Confidence Interval for Odd
The following variables were not statistically significantly related to outcome:
(i) at baseline- age, years of schooling, literacy, marital status, unemployment, unab
healer, family history of mental illness, explanatory models related to disease, karm
GAF score, at least one non- medical explanatory model held, 2 or more explanator
(ii) 6-months follow up data- BPRS scores, explanatory models related to disease, ka
explanatory model held, 2 or more explanatory model held, disease model plus at l
(iii) 12-month follow up data- explanatory models related to karma, punishment by
more explanatory model held, disease model plus at least 1 non-medical model.
(iv) 60-months follow up data- karma, punishment by God, 2 or more explanatory m
(v) Over 5-year course- no. of hospital visits, no. of missed appointments, regularitywith pre-baseline factors (e.g. urban residence, fluctuating
course of initial illness), improved functioning and shorter
duration of total psychotic illness (e.g. better GAF scores at
6 months, lower psychopathology at 12 months). Insight
scores and the presence of at least one non-medical
explanatory model were only associated with remission
later in the course of illness. The disease model was asso-
ciated with remission while individual non-medical models
(e.g. beliefs in evil spirit, black magic) were associated with
poor outcome. These relationships remained statisticallye status Bivariate statistics
sion Not in remission
No. (%)
Odds ratio 95% Confidence
interval
11 (36.7) 2.43* 1.00- 5.93
1 (3.3) 10.27** 1.30-81.30
4 (13.3) 3.33* 1.03-10.73
19 (63.3) 0.41* 0.17-1.003
17 (56.7) 3.75** 1.42-9.91
10 (33.3) 0.28* 0.10-0.81
13 (43.3) 2.33 0.96-5.65
7 (28.0) 3.86** 1.38-10.76
7 (28.0) 3.86** 1.38-10.76
11 (37.9) 2.63* 1.06-6.56
24 (82.8) 0.16*** 0.05-0.47
8 (27.6) 3.94** 1.50-10.33
5 (16.7) 4.29** 1.46-12.58
4 (13.3) 18.35*** 5.59-60.28
48 (73.8) 0.01*** 0.002-0.097
29(96.7) 0.017*** 0.002-0.129
3 (10.0) 27.56*** 7.37-103.1
4 (13.3) 0.10* 0.01-0.95
15 (50.0) 0.10*** 0.03-0.31
14 (46.7) 11.24*** 3.72-33.91
3 (10.0) 25.41*** 6.82-94.64
2 (6.7) 46.67*** 9.94-219.04
28 (93.3) 0.02*** 0.005-0.10
le; SAI-E- Schedule for Assessment of Insight-Expanded; PANSS- Positive and
s Ratio; * = p-value <0.05; ** = p-value <0.01; *** = p-value <0.001
le to buy food, debt, requires carer, precipitating stress, visit to traditional
a, punishment by God, black magic, involuntary admission status, BPRS scores,
y model held, disease model plus at least 1 non-medical model.
rma, punishment by God, black magic, evil spirit, at least one non- medical
east 1 non-medical model.
God, black magic, at least one non- medical explanatory model held, 2 or
odel held.
of follow up.
Table 3 Clinical characteristics associated with remission
at 5-year follow-up- multivariate analysis
Model and Variables Multivariate
statistics1
OR 95% CI
Model for baseline data:2
Residence –urban 19.14 2.07-176.99
Fluctuating course of initial illness 5.16 1.66-16.02
Model for variables at 6-months:2
Fluctuating course of initial illness 2.54 1.03- 6.26
GAF score 2.74 1.20- 6.25
Model for variables at 12-months:2
Residence –urban 11.92 1.38-103.30
BPRS score 0.14 0.04-0.44
Model for variables at 60-months: 2
BPRS score 0.008 0.000-0.17
SAI-E score 16.53 1.50-182.60
At least one non medical explanatory model present 18.69 1.60-218.95
BPRS- Brief Psychiatric Rating Scale; SAI-E- Schedule for Assessment of Insight-
Expanded; PANSS- Positive and Negative Syndrome Scale; OR- Odds Ratio; 95%
CI- 95% Confidence Interval for Odds Ratio; 1- logistic regression; 2- Statistically
significant variables, on bivariate analysis, at specific point in time plus significant
baseline variables (sex, residence, no. of meals/day, duration of untreated psychosis,
fluctuating course of initial illness) included in the model.
Table 4 Individual belief models and remission-
multivariate analysis
Model and Variables1 Multivariate statistics2
OR 95% CI
Model for beliefs at baseline:3
- Explanatory model- evil spirits as causal 0.18 0.04-0.75
- Residence –urban 34.07 2.96-391.95
-Fluctuating course of initial illness 4.18 1.30-13.43
Model for beliefs at 12-months:3
- Explanatory model- disease as causal 2.29 1.06-4.91
- Residence –urban 2.98 1.13-7.66
-Fluctuating course of initial illness 3.04 1.27-7.24
Models for beliefs at 60-months:3
I - Explanatory model- disease as causal 31.65 7.34-136.55
- Residence –urban 26.22 2.16-317.84
- Fluctuating course of initial illness 5.94 1.30-27.18
II- Explanatory model- black magic as causal 0.14 0.04-0.46
- Residence –urban 16.22 1.56-168.75
- Fluctuating course of initial illness 3.54 1.05-11.99
III- Preferred causal explanatory
model – disease model
55.62 9.69-319.31
- Residence –urban 29.11 2.00-424.25
- Fluctuating course of initial illness 7.41 1.33-41.45
IV - Preferred causal explanatory
model – non medical
0.02 0.003-0.10
- Residence –urban 29.14 2.00-424.25
V – Belief in at least one non-medical
explanatory model
11.96 3.52-40.60
VI - Belief in disease model plus at least
one non-medical model
61.45 16.27-232.04
- Residence –urban 3.63 1.03-12.77
VII - Interaction between disease and
non-medical model
3.70 2.15-6.37
- Residence –urban 24.57 1.79-337.12
OR- Odds Ratio; 95%CI- 95% Confidence Interval for Odds Ratio; 1- No
explanatory models significant at 6 months; 2- logistic regression; 3- model
includes belief plus factors known to be associated with knowledge (age, sex,
education, residence) and baseline clinical variables significantly associated
with outcome (no. of meals/day, duration of untreated psychosis, fluctuating
nature of initial illness).
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factors associated with belief systems (e.g. age, sex, resi-
dence, education) and significant baseline variables. There
was a significant interaction effect between disease explan-
ation and non-medical explanatory models illness and
remission. The relationship between remission and the dif-
ferent explanatory model variables, at 60 months, remained
statistically significant even after adjusting for regularity of
follow up over the 5-year period. Remission, insight scores
and number of non-medical explanatory models of illness
held were not significantly associated with number of hos-
pital visits, the number of missed appointments or regular-
ity of follow-up.
The association between remission and changes in
SAIE and BPRS scores between baseline and 6 and
12 months were tested for statistical significance. The
only significant variable associated with remission were
reduction in BPRS score between baseline and 12 months
(t =−3.16; df = 87; p = 0.002), which remained significant
(OR=0.91; 95% CI 0.85-0.98; p = 0.01) after logistic regres-
sion analysis adjusting for other clinically significant vari-
ables. Changes in insight scores during the first year of
treatment were not associated with outcome at 5 years.
Analysis of repeated measures
Figures 1 documents the serial insight and psychosis rat-
ings and Figure 2 records the numbers of explanatory
models of illness over the 5 year period. BPRS scoresshowed consistent decline while there was a steady in-
crease in insight scores, number of patients who held
disease model and those who simultaneously subscribed
to disease and at least one non-medical model. The
number of subjects who held at least one non-medical
model was high at baseline, decreased with reduction in
psychosis and treatment response and then seemed to
increase with the stabilization of the course and out-
come of illness.
The data was analysed using Generalized Estimating
Equations (GEE) to assess the impact of serial assessments
Figure 1 Insight and psychosis ratings over time.
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on serial BPRS scores. Baseline variables significantly asso-
ciated with remission and the number of visits to the hos-
pital were entered as fixed variables in the model to adjust
for their effects. Women (B=−2.65; SE= 1.03; p = 0.01),
rural residence (B=− 2.06; SE= 1.00; p = 0.038), SAI-E
scores (B=− 0.65; SE= 0.04; p = 0.000) and number of
non-medical models (B= 5.31; SE= 0.91; p = 0.000) were
significantly associated with BPRS scores. The non-
significant variables in the model were: number of meals
per day, duration of untreated psychosis, fluctuating initial
course, and number of visits to hospital.Figure 2 Number and types of explanatory models over time.Discussion
This is probably the first study with a large sample and a
long period of follow-up, which has systematically exam-
ined psychopathology, insight, indigenous explanatory
models of illness and outcome in schizophrenia. Its
strengths include prospective cohort, detailed and
repeated standard assessments of psychopathology and
insight, assessment of both disease models and non-
medical explanatory models of illness, a 5-year follow-
up, and multivariate statistical procedures to adjust for
confounders and to analyze repeated and correlated
data. The fact that about a quarter of the original sample
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psychopathology and insight assessments between 12
and 60 months are limitations.
The study has documented heterogeneity of outcome
in schizophrenia. It recorded the simultaneous accept-
ance of multiple and contradictory explanatory models
of illness and diverse sources of help seeking. Psycho-
pathology, insight and explanatory models changed over
the 5-year period. The proportion of patients holding
disease models steadily increased over time with over
half the subjects preferring it as the best explanation at
5 years. The number of patients holding non-medical
models was high at recruitment, reduced over the first
year of treatment and then rose dramatically. Urban resi-
dence, fluctuating course of the initial illness, improve-
ment in functioning at 6 months and lower psychosis
rating at 12 months were significantly related to remis-
sion. Insight scores and non-medical explanatory models
held during the later course of the illness were signifi-
cantly associated with outcome at 5 years. Disease mod-
els were associated with remission while non-medical
were associated with poorer outcome. However, there
was interaction between medical and non-medical mod-
els. The presence of the disease model and at least one
indigenous model had a stronger impact on remission
than the disease explanation per se. Analysis of longitu-
dinal data showed that women, rural residence, insight
scores and the number of non-medical explanatory
models of illness held were significantly associated with
BPRS scores during the study period.
Insight and explanatory models
Many investigations have recorded the simultaneous
presence of multiple and contradictory models of illness
in people [8,18-23]. This is considered the norm in low
and middle income countries but has also been recorded
in western populations [20,24]. Previous studies have
documented high insight scores in people who subscribe
to disease models [8,9,19]. In addition, investigations
who have examined non-medical models have demon-
strated their negative relationship with insight scores
[8,19]. Nevertheless, such correlations are natural con-
sidering the fact the instruments, which assess insight
focus on disease explanations, attributions and actions,
and concentrate on the recognition of mental illness at-
tribution and seeking medical and psychiatric treatment.
These instruments do not consider locally and culturally
relevant attributions and help seeking.
Insight, explanatory models and psychopathology
The reduction of psychotic symptoms and improved
functioning during the first year of treatment is asso-
ciated with an increase in the use of disease explanations
and a marked reduction of causal non-medical beliefs.However, the number of people subscribing to disease
explanations tends to plateau with only about half the
subjects preferring it at 5 years. The pattern of change in
the number of indigenous models of illness employed
argues that they help coping. Their manifest reduction
at 6- and 12-month follow-up coincides with the reduc-
tion in psychosis for all patients. Their marked increase
at 60 months suggests their role as a coping strategy
when the pattern of course and outcome of illness
becomes established. Previous studies have documented
the inverse relationship between psychopathology and
insight [8,9,19,47-49]. However, many of these studies
focused on cross-sectional and early illness data or had
failed to adjust for many illness characteristics.
Factors associated with outcome
The fact that pretreatment illness variables, improve-
ment in functioning and reduction in psychopathology
determined outcome at points in time before insight
scores and explanatory models were significant suggest
their major role in the process. The bivariate statistical
association during the early course of illness between
insight, explanatory models and outcome, lost their stat-
istical significance when baseline and clinical variables
were included in the multivariable analysis arguing that
such relationships are confounded by illness characteris-
tics. The independent predictor status of insight and ex-
planatory models for clinical remission only becomes
significant late in the course of illness. The positive rela-
tionship between insight and the number of non-
medical explanatory models of illness, their negative
relationship with psychopathology argues their impact
on outcome is possibly secondary to the inherent nature
of the disease. The relationships persisted after adjusting
for the number of hospital visits.
These findings challenge the direction of the relation-
ship between insight and psychopathology arguing that
insight may be secondary to psychopathology. The asso-
ciation of insight and non-medical explanatory models
to long-term outcome later in the course of illness sug-
gests that explanatory models are coping mechanisms
rather than being causally related to outcome.
The inverse correlation between insight scores and psy-
chopathology in earlier reports [19,47-49] did not examine
its impact on long-term outcome and take into consider-
ation the time course of the illness. Although many studies
have documented good insight as predictor of outcome,
this relationship may be confounded by illness variables,
which are usually not systematically excluded. The fact
that pre-treatment variables and current psychopathology
confound the relationship between explanatory models of
illness at all points of time makes it difficult to conclu-
sively argue that insight predicts longer-term outcome.
Our data suggests the reverse, that psychopathology and
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and outcome in schizophrenia.
The heterogeneity of clinical features, course, outcome
and treatment response of schizophrenia probably
reflects different diseases, illnesses and trajectories. The
fact that non-medical beliefs held during the later part
of the illness were associated with non-remission and
treatment non-response suggests that patients with a
worse course and outcome and poorer response to treat-
ment may select such explanatory models to cope with
the devastating impact of their illness.
Explanatory models, stigma and coping
Pluralistic societies employ multiple approaches to
health and illness. The simultaneous use of contradictory
models suggests their use in coping with different
aspects of the condition [27]. The fact that people with
non-medical beliefs were willing to take anti-psychotic
medication argues for the complexity of the issues
demanding a nuanced understanding of explanations
and coping mechanisms. The persistence of the associ-
ation between poor outcome and non-medical causal
models, after adjusting for regularity of hospital follow-
up, suggests that they are coping mechanisms for poor
outcome conditions.
Mental illness and their labels are stigmatizing across
cultures leading to much prejudice and discrimination.
This is particularly significant in people with residual
and poor outcome schizophrenia whose limited response
to medication, adverse effects and continued symptoms
demands the need for explanations, which go beyond
simple disease. Non-medical, supernatural and external
explanatory models seem to be preferred to disease
explanations in order to cope with the devastation of the
disease in people who have not recovered with treat-
ment. They seem to be culturally acceptable mechanism
to cope with complex and incapacitating outcomes. The
persistence of multiple explanatory models of across cul-
tures for chronic illnesses may suggest an evolutionary
advantage.
Insight as narrative
Medicine and psychiatry, despite their attempts at a uni-
versal understanding of mental disorders, cannot do
justice to patients without the recognition of the con-
texts and the sharing of personal narratives. Psychiatry
with its focus on objective behaviours, symptom check-
lists and diagnostic criteria has reduced the importance
of patient experience and narratives [50]. Illness narra-
tives contextualise the patient. They capture the indivi-
dual’s suffering in an everyday context, in contrast to the
medical narratives that reflect the needs of psychiatry.
Patient experiences are particularly important for psy-
chiatrists and mental health professionals who workevery day with people with chronic and disabling mental
illnesses but have never actually walked in their shoes.
Illness narratives refocus the doctor-patient interaction
and provide a window into the patient’s reality and his/
her ways of coping [51].
The lack of laboratory tests to diagnose mental disor-
ders tends to raise doubts about their diagnostic cer-
tainty making many patients and their families uncertain
and uncomfortable about psychiatric labels [52]. In
addition, negative attitude related to mental illness
abound in most societies, result in stigma and lead to
discrimination. The acceptance of such diagnostic labels
can reduce self-esteem among patients. Patients, conse-
quently, refuse to accept biomedical models and expla-
nations for their experience and conditions.
The subjective dimension of insight has been concep-
tualized as a particular form of narrative production,
called narrative insight [53]. Explanatory models of
patients and their families are narratives to make sense
of and convey experiences of illness, control them, main-
tain or improve quality of life [52]. These narratives can
increase empathic understanding of illness experiences
and life events, reduce their threat, provide some degree
of control over these phenomena and incidents and im-
prove their quality of life. They may often be effective
aids to coping, particularly for treatment-resistant symp-
toms and deficits and incapacitating medication side
effects.
There is a need to reconcile personal narratives with
the biomedical model so that many personal strategies
employed to coping with mental illness are not devalued
or dismissed. Such experiential knowledge, although per-
sonal, will have to be recast in each case. It will help
translate experience, provide legitimate frameworks and
create a language and interface for improved communi-
cation [50]. The reframing of such narratives will impact
psychiatric care, practice, research and health care deliv-
ery systems. Patient experience and perspectives, deva-
lued and delegitimized by canonical authority, needs to
be reemphasized and integrated into clinical practice.
There is a need to foreground patient experience in
order to impact the mainstream psychiatric discourse.
Explaining insight
It has been argued that insight is shaped by psychology
(i.e. motivation and denial) and constraints of biology
(i.e. cognitive impairment and anosognosia) and is
influenced by social constructions of illness (e.g. culturally
specific explanatory models) [6,7]. Its comparison to ano-
sognosia, as in brain disease and damage, may not be very
useful as its response to antipsychotic medication and
change over time and limit such comparison. Similarly, its
attribution to cognitive impairment is less than definitive in
view of its response to antipsychotic medication, which is
Table 5 Current and proposed dimensions of insight
Current dimensions of
insight [4]
Proposed dimensions of insight
[14,54]
Ability to re-label psychotic
experience as abnormal
Ability to re-label psychotic experience
as abnormal
Awareness of mental illness Change is attributed to and corresponds
with local beliefs for illness. This can
include the simultaneous use of multiple
and contradictory explanations.
Seek medical treatment Acknowledge the need for restitution
and seek available intervention/
treatment. This can include the
concurrent or sequential use of diverse
interventions from varied facilities
offering cure and healing.
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deficits in schizophrenia. Its reciprocal relationship with
psychopathology during the initial course of schizophrenia
suggests its association with delusional thinking and beliefs.
Severe delusional illnesses, by their definition, preclude
alternative explanations especially at the height of the ill-
ness and in those with severe disease.
The association of disease models of illness in those with
good response to treatment and the correlation between
non-medical illness explanations and poor response sug-
gests their role in coping. The complex interaction
between disease and indigenous models and the impact
on remission argues for a nuanced understanding of the
relationships between explanatory models and outcome.
The complexity of schizophrenia, its heterogeneity in
course and outcome, its varied response to antipsychotic
medication and its unpredictable impact on diverse
aspects of life seem to elicit a multifaceted response from
people who suffer from it, their relatives and from society.
Framing insight
Insight is not just the possession of discrete facts about
the nature of mental illness. Nor is it only an acknow-
ledgement of a particular experience as abnormal. It is also
not an acceptance of a singular truth about the person
and his/her life. An awareness of a mental illness is a nar-
rative act in which people make personal sense of the
many challenges they face. Such challenges include per-
sistent psychotic symptoms, negative syndrome, cognitive
deficits, impaired social relations, perpetual instability and
livelihood issues. The patient’s narrative of the illness
would then vary according complexity of the problem and
context. The insight narrative would also vary according
to its role in coping and adapting to the new challenges
and demands. The cultural context, acceptable cultural
explanations and the prevalent social stigma related to
mental illness would interact with the person’s illness to
produce a particular understanding. The complexity of
issues calls for a nuanced framing of insight.
Defining insight
Alternative conceptualisations of insight have employed
findings from investigations in the non-western cultures
[14,22-24,27,54]. These findings include: (i) patient’s
often provide non-medical explanations for the cause of
illness (e.g. karma, evil spirits, black magic, sin, punish-
ment by God, etc.), (ii) mental illness labels are very stig-
matising across cultures and settings, (iii) many subjects
simultaneously hold multiple, diverse and contradictory
beliefs and reflect the pluralistic approach of patients,
(iv) many patients simultaneously seek biomedical and
non-biomedical interventions from a variety of healers
and centres of cure and healing. These findings argue
that the current multidimensional models are notculturally sensitive to assess insight. They suggest that it
is difficult to have definable, objective or universal stand-
ard for insight. They argues that there is a need for uni-
versal conventions to compare individual explanations
with sub-cultural perceptions [14,54].
Alternative dimensions have been suggested for the
assessment of insight (Table 5) [14,54]. Insight should be
assessed against local and cultural standards of providing
non-delusional and culturally acceptable explanations
and attributions and seeking locally acceptable and avail-
able interventions. The findings of this study also sug-
gest that subscribing to multiple explanatory models of
illness argues that it is a pragmatic response to the dev-
astation of chronic and residual psychosis. The assess-
ment of insight should be similar to the assessment of
other clinical phenomena like delusions, which involve
comparison with local and cultural yardsticks [14,54].
The findings argue for the fact that the assessment of
insight should be against the local cultural standards in-
cluding disease models rather than universal yard-
sticks (e.g. of solely employing biomedical models). The
assessment of insight should evaluate awareness, attribution
and action. People with psychosis who are able to re-label
their psychotic experience, offer non-delusional explana-
tions for changes in themselves, which correspond to beliefs
about illness held by the subculture, admit to the need for
restitution, and seek locally available help, can be said to
possess insight. The results recommend the use of universal
conventions (of awareness, attribution to locally accepted
non-delusional explanations and seeking available help) to
assess insight in people with psychosis rather than the use
of uniform criteria which focus solely on the biomedical
model of disease.
Clinical and research implications
Many people hold multiple causal and treatment models
of their illness [55]. This is particularly true for chronic
and disabling illnesses, which do not completely respond
to medication and treatment. Attempts at elicitation of
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ness in addition to the biomedical model will provide
clinicians with an understanding of residual problems
and disability and the patient’s attempt at coping. While
medication compliance is crucial to the reduction of
psychotic symptoms and the maintenance of remission,
other non-medical models also help in providing a prag-
matic response to the persisting symptoms and pro-
blems. Non-medical beliefs should not be challenged or
dismissed and the clinician should not claim exclusivity
or superiority of the biomedical model. The use of di-
verse coping strategies for healing should be encouraged
while emphasising medication compliance. Assessing
insight in clinical practice will mandate the need to elicit
all causal explanatory models and identify the diversity
of help seeking. The use of a combination of different
explanations including the biomedical model suggest
attempts at coping employing many diverse culturally
sanctioned strategies reflecting a greater awareness of
the illness as well as the local context and environment
(i.e. insight).
Research into insight in psychosis should also include
non-medical belief models and move beyond pure bio-
medical explanations. There is a need to develop and re-
fine instruments, which are able to capture diverse belief
systems commonly employed by people with mental ill-
ness and also elicit local explanatory models of illness,
their attribution and help seeking.
Moving forward
The findings of this study mandate replication. The sole
use of biomedical perspectives in the evaluation of re-
sponse to complex diseases needs to be replaced with a
broad based approach and understanding of coping across
cultures. People employ diverse approaches to maintain
mental health. The partial solutions offered by individual
systems of medicine force people to employ diverse and
multiple strategies to cope with distressing symptoms and
intractable problems. Consequently, there is a need for a
non-judgemental approach to the explanatory models
employed by people with mental illness. While anti-
psychotic medication has a powerful impact on outcome,
the use of other strategies especially in chronic conditions
to cope with the variable impairment, disability and handi-
cap, even among those with clinical remission, suggest the
need to allow patients to use multiple strategies to regain
and maintain mental health.
Cultural knowledge, empathy and an understanding of
its complex interaction, which impact diseases and shape
the illness response, is crucial to providing culturally sensi-
tive care. Presenting biomedical perspectives without dis-
missing patient beliefs and negotiating a shared treatment
plan without claiming exclusivity are cardinal. This will
allow mental health professionals to bridge the disease-illness and the healing-cure divides across all cultures and
settings. The complexity of the issues demonstrated high-
light the need for a nuanced understanding of issues
related to insight, explanatory models of illness and cul-
ture in schizophrenia and for other chronic illness.
Conclusion
This 5-year cohort study of people with first episode
schizophrenia systematically examined psychopathology,
insight, explanatory models, course and outcome. Illness
variables at baseline and during the early course of the ill-
ness predicted outcome at 5 years, while insight scores and
non-medical explanatory models later in the course of ill-
ness were associated with long-term outcome. The positive
relationship between insight and the number of non-
medical explanatory models of illness, their negative rela-
tionship with psychopathology argues that association with
outcome is possibly secondary to the inherent nature of
the disease. These findings challenge the direction of the
relationship between insight and psychopathology. They
argue that insight and explanatory models are coping
mechanisms secondary to psychopathology and course of
the illness rather than being causally related to outcome.
Insight, the disease model and the number of non-
medical model positively correlated with improvement
in psychosis arguing for a complex interaction between
the culture, context and illness variables. The awareness
of mental illness is a narrative act in which people make
personal sense of the many challenges they face. The
course and outcome of the illness, cultural context, ac-
ceptable cultural explanations and the prevalent social
stigma interact to produce a complex and multifaceted
understanding of the issues. This complexity of issues
related to disease, illness, context and culture call for a
nuanced framing of insight.
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